Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Giorgio Guzzi"'
Autor:
Andrea Lechiancole, Sandro Sponga, Giovanni Benedetti, Arianna Semeraro, Giorgio Guzzi, Cristian Daffarra, Matteo Meneguzzi, Chiara Nalli, Daniela Piani, Marilyn Bressan, Ugolino Livi, Igor Vendramin
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
Heart transplantation (HTx) represents the current best surgical treatment for patients affected by end-stage heart failure. However, with the improvement of medical and interventional therapies, the population of HTx candidates is increasingly old a
Externí odkaz:
https://doaj.org/article/f71bc5641d5f4a9b9da57c18d67bc8d0
Autor:
Andrea Lechiancole, Sandro Sponga, Giovanni Benedetti, Igor Vendramin, Massimo Maiani, Enrico Spagna, Giorgio Guzzi, Veronica Ferrara, Ugolino Livi
Publikováno v:
European Journal of Transplantation. 1:13-20
Autor:
Andrea Lechiancole, Veronica Ferrara, Sandro Sponga, Giovanni Benedetti, Giorgio Guzzi, Chiara Nalli, Concetta Di Nora, Massimo Maiani, Enrico Spagna, Cristian Daffarra, Daniela Piani, Matteo Meneguzzi, Marilyn Bressan, Rubens Maria Calandruccio, Ylenia Brindicci, Igor Vendramin, Ugolino Livi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::748b0b3bd620eef08c27e6e9f14d4c0d
https://hdl.handle.net/11390/1244789
https://hdl.handle.net/11390/1244789
Autor:
Veronica Ferrara, Igor Vendramin, Ugolino Livi, Giorgio Guzzi, Concetta Di Nora, Chiara Nalli, Andrea Lechiancole, M. Maiani, Nunzio Davide de Manna, Sandro Sponga, Uberto Bortolotti, A. Dave Nagpal
Publikováno v:
Journal of Cardiovascular Medicine. 22:388-395
AIMS We aimed to describe how treatment of patients in cardiogenic shock bridged to heart transplantation with mechanical circulatory support, using either biventricular assist devices (BVADs) or extracorporeal life support (ECLS), has evolved in the
Autor:
Umberto Baccarani, Gian Luigi Adani, Andrea Risaliti, Ugolino Livi, Riccardo Pravisani, Itzhak Avital, Giorgio Guzzi
Publikováno v:
Transplant International. 33
Autor:
Andrea Lechiancole, Ugolino Livi, Veronica Ferrara, Igor Vendramin, Giorgio Guzzi, Concetta Di Nora, Sandro Sponga, Uberto Bortolotti, Chiara Nalli
To evaluate the impact of donor-recipient age matching on clinical outcomes after heart transplantation, a total of 509 patients (January 1990-December 2018, mean follow-up 111 ± 80 months) were stratified into 4 groups (young-R/young-D, young-R/old
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38136df4fc2cc4f2161d08cfdd32ad0d
http://hdl.handle.net/11390/1189211
http://hdl.handle.net/11390/1189211
Autor:
Concetta Di Nora, Sandro Sponga, Chiara Nalli, Mauro Driussi, Igor Vendramin, Giovanni Benedetti, Giorgio Guzzi, Massimo Imazio, Ugolino Livi
Publikováno v:
Vessel Plus. 6:46
It is known that the prognosis of patients affected by light-chain (AL) or transthyretin-related (TTR) amyloidosis is poor. TTR amyloidosis has usually shown a slower progression than AL amyloidosis, both hereditary TTR amyloidosis, where there is an
Autor:
Veronica Ferrara, Giorgio Guzzi, V. Tursi, Andrea Lechiancole, C. Di Nora, Chiara Nalli, Sandro Sponga, Ugolino Livi
Publikováno v:
European Heart Journal. 40
Increasing recipient (RA) and donor age (DA) are independently associated with mortality after Heart Transplantation (HT). The aim of this study was to analyse the impact of age-matching on HT survival. 485 recipients who underwent HT between 1990 an
Autor:
Veronica Ferrara, Igor Vendramin, Giorgio Guzzi, C. Di Nora, Ugolino Livi, Sandro Sponga, Andrea Lechiancole, Chiara Nalli, P. Daniela
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S257
Purpose The distance of recipients residency from the heart transplant (HT) Center could condition the treatment received, and thus long-term results. Aim of the study was to verify the impact of the distance from our Center on long-term outcome afte
Autor:
Fabio Ius, Tim Kaufeld, Gregor Warnecke, Andrea Lechiancole, Ugolino Livi, Sandro Sponga, S. Royas, Axel Haverich, Wiebke Sommer, Veronica Ferrara, Giorgio Guzzi
Publikováno v:
The Journal of Heart and Lung Transplantation. 39:S245
Purpose Recently, it has been shown that survival after heart transplantation is impaired in patients bridged with left ventricular assist devices (LVAD), mostly due to increased rates of primary graft dysfunction (PGD). Ex vivo perfusion (EVP) is a